The Technical Analyst
Koninklijke Philips N.V. [PHG]
Exchange: NYSE Sector: Healthcare Industry: Medical Devices
Koninklijke Philips N.V. Price, Forecast, Insider, Ratings, Fundamentals & Signals
5.56% $26.48
America/New_York / 9 mai 2024 @ 11:12
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 24 002 mill |
| EPS: | -0.930 |
| P/E: | -28.47 |
| Earnings Date: | Jul 22, 2024 |
| SharesOutstanding: | 906.40 mill |
| Avg Daily Volume: | 1.278 mill |
| RATING 2024-05-08 |
|---|
| C+ |
| Sell |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Neutral | |
| DE: | Sell | |
| P/E: | Sell | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | 1/24 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | n/a | n/a | ||||
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -28.47 | sector: PE 15.43 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| 0x |
| Company: PE -28.47 | industry: PE -41.13 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$9.05 (-65.81%) $-17.43 |
| Date: 2024-05-09 |
| Expected Trading Range (DAY) |
|---|
|
$ 26.11 - 26.81 ( +/- 1.33%) |
| ATR Model: 14 days |
Forecast:
12:51 - $26.49
Live Trading Signals (every 1 min)
Forecast
1: 11:21 - $26.46
Forecast 2: 12:11 - $26.48
Forecast 3: 12:51 - $26.49
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $26.48 (5.56% ) |
| Volume | 0.483 mill |
| Avg. Vol. | 1.278 mill |
| % of Avg. Vol | 37.81 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For PHG
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
PHG
Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Latest Press Releases
2024-05-07 11:30:00 - Press Release
Philips Shareholders Approve All Proposals At The Agm 2024
May 7, 2024 amsterdam, the netherlands – royal philips (nyse: phg, aex: phia), today announced that its shareholders approved all proposals at the annual general meeting of shareholders (agm) 2024, including: the re-appointment of chairman feike sijbesma and peter lÖscher as members of the supervisory board. the appointment of benoÎt ribadeau-dumas as member of the supervisory board.
2024-05-07 10:00:00 - Press Release
Philips Avent Supports March Of Dimes' It Starts With Mom Initiative To Help New Moms Access Resources To Prioritize Their Health And Well-being
Philips avent introduced share the care brand positioning in march 2024 , encouraging families, friends and communities to better support moms so they can prioritize their well-being and self-care. cambridge, mass.
2024-04-30 09:00:00 - Press Release
Nicklaus Children's Health System, Philips To Provide Innovative Patient And Staff Experience, Helping To Enhance Outcomes For The Smallest Of Patients
April 30, 2024 philips ai-enabled diagnostic and experiential technologies help put patients at ease while empowering staff with faster, high-quality scans and increased diagnostic confidence amsterdam, the netherlands, and miami, us – royal philips (nyse: phg, aex: phia), a global leader in health technology, and nicklaus children's health system, a nationally recognized leader in pediatric care, today announced a 10-year long-term strategic collaboration aimed at enhancing the patient and staff experience, enhancing outcomes and driving innovation in pediatric care. serving over 500,000 patients a year, nicklaus children's will adopt philips technologies such as the ingenia ambition x mr and epiq cvx ultrasound, with ai-enabled radiology workflow solutions to reduce exam times and the need for rescans, while increasing diagnostic confidence, resulting in faster diagnosis and treatment for patients.
2024-04-29 01:00:00 - Press Release
Philips Delivers First-quarter Results In Line With 2024 Performance Improvement Plan; Resolves The Respironics Personal Injury And Medical Monitoring Litigation In The Us For Usd 1.1 Billion
April 29, 2024 first-quarter highlights group sales amounted to eur 4.1 billion, with comparable sales growth of 2.4% comparable order intake -3.8%, mainly due to china usd 1.1 billion respironics litigation settlement reached in the us (provision recognized of eur 982 million) income from operations eur -824 million, including above provision adjusted ebita margin of 9.4% of sales free cash outflow of eur 336 million eur 540 million agreement reached with insurers for respironics recall-related product liability claims roy jakobs, ceo of royal philips: “we started the year in line with our plan, with order intake growth outside china turning positive and strong margin improvement. supported by key innovation launches and strong focus on our execution priorities, we remain confident in our performance improvement plan for 2024.
2024-04-10 02:05:00 - Press Release
Philips Respironics Reaches Agreement With Us Government On A Consent Decree Creating A Clear Path Forward
April 10, 2024 philips confirms that further to communicating the main terms of the philips respironics consent decree on january 29, 2024, philips' subsidiaries philips holding usa and philips respironics have now reached final agreement on the consent decree with the doj and fda. as previously stated: the consent decree primarily focuses on philips respironics' business operations in the us.
Latest News
2024-05-08 12:40:35 - Zacks Investment Research
PHG vs. HAE: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical - Products sector have probably already heard of Royal Philips (PHG) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?
2024-05-08 10:46:41 - Zacks Investment Research
Why Royal Philips (PHG) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
2024-05-01 05:31:12 - Finbold
Insider trading? Health subcommittee member buys stock before lawsuit settlement
Insider traders often operate on undisclosed information, giving them an unfair edge in forecasting stock market movements.
2024-04-30 12:46:12 - Zacks Investment Research
Philips (PHG) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
Philips' (PHG) first-quarter results benefit from strong momentum across the Diagnosis & Treatment and Personal Health businesses. However, softness in the Connected Care business is a concern.
2024-04-29 16:18:08 - Yahoo Finance
Philips stock soars on $1.1 billion respiratory device settlement
Koninklijke Philips (PHG) reached a $1.1 billion settlement over a US device recall for its respiratory ventilator devices, causing shares of the company to jump on Monday. The payment was originally estimated by some analysts to be more than $2 billion, putting to bed many worries from investors.
2024-04-29 11:56:05 - Investopedia
Philips Stock Soars as Company Reaches $1.1B Settlement in US for Sleep Apnea Devices
Koninklijke Philips (PHG) shares traded in the U.S. soared nearly 30% Monday morning after the Dutch medical devices giant agreed to a $1.1 billion settlement to pay out personal injury cases in the U.S. linked to the recall of some of its sleep apnea devices.
2024-04-29 11:31:36 - Fox Business
Philips pays $1.1B to settle sleep apnea device suits
Philips Respironics announced that it agreed to pay over a billion dollars to settle claims stemming from the 2021 U.S. recall of its sleep therapy devices.
2024-04-29 11:30:00 - CNBC International TV
Philips settles U.S. respiratory device case
Subscribe to CNBC International TV: http://cnb.cx/2wAkfMv Subscribe to CNBC International: http://cnb.cx/2gft82z LinkedIn: https://www.linkedin.com/showcase/cnbc-international/ TikTok: https://www.tiktok.com/@cnbci Facebook: https://www.facebook.com/cnbcinternational Instagram: https://www.instagram.com/cnbcinternational/ Threads: https://www.threads.net/@cnbcinternational X: https://twitter.com/CNBCi Telegram: https://t.me/cnbci
2024-04-29 09:00:55 - CNBC International TV
'Vast majority' of legal cases over apnea recall now settled: Philips CEO
Philips CEO Roy Jakobs comments on the company's first-quarter results and its agreement of a $1.1 billion settlement for personal injury and medical monitoring claims linked to the recall of some respiratory devices.
2024-04-29 07:17:16 - Proactive Investors
Philips soars after settling sleep apnea class action for $1.1bn
Dutch multinational Philips soared a remarkable 43% on Monday after settling a protracted class-action lawsuit in the US over allegedly faulty sleep apnea devices. Millions of the devices were recalled over fears that the polyester-based polyurethane foam used to reduce noise could break down and become toxic, potentially causing cancer.